Gelişmiş Arama

Yazar "0000-0003-3692-163X" için listeleme

Toplam kayıt 3, listelenen: 1-3

    • HPLC method for simultaneous quantification of lumacaftor and ivacaftor bulk and pharmaceutical formulations 

      Anadolu Üniversitesi; 0000-0002-5492-0457; 0000-0001-8467-478X; 0000-0003-3692-163X; Özcan, Saniye; Elbiş, Abeer; Levent, Serkan (Anadolu Üniversitesi, 2023)
      In 2015, the Food and Drug Administration granted approval for the use of lumacaftor 200 mg and ivacaftor 125 mg in the treatment of cystic fibrosis patients who possess the F508del mutation, namely those who are 12 years ...

    • A new HPLC method for selexipag analysis in pharmaceutical formulation and bulk form 

      Anadolu Üniversitesi; 0000-0002-5492-0457; 0009-0007-6708-1166; 0000-0003-3692-163X; 0000-0003-0280-518X; Özcan, Saniye; Öğüt, Egemen Güvenç; Levent, Serkan; Can, Nafiz Öncü (Anadolu Üniversitesi, 2023)
      Selexipag is a new non-prostanoid prostacyclin receptor agonist used to treat pulmonary arterial hypertension. Selexipag is a long-acting IP receptor agonist with a shorter half-life than all other licensed drugs targeting ...

    • Review of an up-to-date, emphatic, and concise perspective on e-cigarettes 

      Anadolu Üniversitesi; 0000-0002-5492-0457; 0009-0007-6708-1166; 0000-0003-3692-163X; 0000-0003-0280-518X; Özcan, Saniye; Öğüt, Egemen Güvenç; Levent, Serkan; Öncü Can, Nafiz (Anadolu Üniversitesi, 2024)
      Electronic cigarettes entered the market in 2007 as an alternative to conventional tobacco products, and their use has increased significantly worldwide. Due to the emergence of various harmful effects and attracting ...